NCT03994809|Completed
International Study of Biofield Therapy
International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms
Loading search results
International Cross-sectional Study on the Effectiveness of Biofield Therapy for the Relief of Various Symptoms
Sponsor study identifier
observational
12,000
0 countries
N/A
Study Start
January 1, 2008
Actual (reported)Primary Completion
September 30, 2010
Actual (reported)Study Completion
September 30, 2010
Actual (reported)Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 30, 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2008
Actual (reported)September 30, 2010
Actual (reported)September 30, 2010
Actual (reported)June 17, 2019
Actual (reported)June 21, 2019
Actual (reported)improvement/exacerbation rate of symptoms after a single session of biofield therapy
The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.
Up to one year after all the data were collected.
adjusted odds ratio of the factors associated with the changes in symptoms
Logistic regression analyses
Up to one year after all the data were collected.
The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Participants were recruited in various settings, including the workshop, the investigator's house, or the participant's home in 14 different countries.
Suzuki K, Uchida S, Kimura T, Tanaka H, Katamura H. International Cross-Sectional Study on the Effectiveness of Okada Purifying Therapy, a Biofield Therapy, for the Relief of Various Symptoms. J Altern Complement Med. 2020 Aug;26(8):708-720. doi: 10.1089/acm.2019.0264. Epub 2020 Jun 17.
Kiyoshi Suzuki, MD, PhD
MOA Health Science Foundation
12,000 participants (actual enrollment reported by the registry).
First Submitted
June 17, 2019
First Posted
June 21, 2019
Study Start
January 1, 2008
Actual (reported)Observational Study on the Patients With Pain Medications
Contact the study team to confirm eligibility.
Primary Completion
September 30, 2010
Actual (reported)Study Completion
September 30, 2010
Actual (reported)Last Updated
June 21, 2019
Record last verified: 2019-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: